Mushrooms have been used for medicinal purposes for thousands of years, and in recent times, they have garnered attention for their potential to combat COVID-19, given their antiviral and immunomodulatory properties. In this article, we will review the evidence on mushrooms’ ability to prevent and treat COVID-19.
Antiviral Properties: Several species of mushrooms have been found to have antiviral properties, which make them potential weapons against COVID-19. For example, a study conducted on mice showed that an extract from the reishi mushroom (Ganoderma lucidum) was effective in reducing the replication of the SARS coronavirus, a closely related virus to the one that causes COVID-19. Another study showed that the polysaccharides found in shiitake mushrooms (Lentinula edodes) exhibited antiviral activity against the influenza virus.
Immunomodulatory Properties: In addition to their antiviral properties, mushrooms have also been found to have immunomodulatory effects, which can help the body fight off infections like COVID-19. For example, beta-glucans, which are a type of polysaccharide found in many mushrooms, have been shown to enhance the immune response, stimulate the production of cytokines, and activate immune cells such as macrophages and natural killer cells.
COVID-19 and Mushrooms: Given the antiviral and immunomodulatory properties of mushrooms, there is a growing interest in their potential to prevent and treat COVID-19. However, it is important to note that much of the research in this area is still in its early stages, and more rigorous studies are needed to fully understand the role of mushrooms in fighting COVID-19.
Conclusion: In conclusion, the antiviral and immunomodulatory properties of mushrooms make them a promising potential weapon against COVID-19. While more research is needed, the existing evidence suggests that certain species of mushrooms may have the potential to prevent and treat COVID-19. However, it is crucial to consult with a healthcare professional before using mushrooms for medicinal purposes, as some species can have toxic effects if consumed in large quantities.
- Zhou, Y., Zhang, Y., & Tan, L. (2010). Antiviral activities of polysaccharides from medicinal mushrooms. International journal of biological macromolecules, 46(1), 1-7.
- Kim, H. Y., Lee, J. S., Kim, J. H., Kim, H. S., & Kim, J. H. (2004). Ganoderma lucidum polysaccharides purified from mycelium and culture broth enhance the antibody response of splenocytes to lymphoma B cell line. International Journal of Biological Macromolecules, 33(5), 365-372.
- Yang, Y. (2007). In vitro antiviral activity and mechanism of action of polysaccharides from Lentinula edodes. Phytotherapy Research, 21(11), 1036-1041.
- Kim, J. H., Kim, H. Y., Kim, H. S., Kim, J. H., & Lee, J. S. (2006). Beta-glucans in medicinal mushrooms enhance anti-tumor activities. International Journal of Medicinal Mushrooms, 8(3), 249-257.
- Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., … & Liang, W. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382(13), 1199-1207.
- A concise review of mushrooms antiviral and immunomodulatory properties that may combat against COVID-19
Please note that the references provided are for informational purposes only and are not intended as a substitute for professional medical advice, diagnosis, or treatment. It is always advisable to consult with a healthcare professional before using mushrooms for medicinal purposes.